Content validity of patient-reported outcomes for use in lower-risk myelodysplastic syndromes

Abstract Background The lower-risk (low and intermediate-1 risk based on IPSS) myelodysplastic syndrome (MDS) has a negative impact on patients’ health-related quality of life (HRQoL). Patient Reported Outcomes (PROs) instruments, which are used to collect patients’ HRQoL data, should have establish...

Full description

Bibliographic Details
Main Authors: Jeremiah J. Trudeau, Jianming He, Esther Rose, Charlotte Panter, Sharan Randhawa, Adam Gater
Format: Article
Language:English
Published: SpringerOpen 2020-08-01
Series:Journal of Patient-Reported Outcomes
Subjects:
Online Access:http://link.springer.com/article/10.1186/s41687-020-00235-4